0001209191-18-030207.txt : 20180515
0001209191-18-030207.hdr.sgml : 20180515
20180515162125
ACCESSION NUMBER: 0001209191-18-030207
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180511
FILED AS OF DATE: 20180515
DATE AS OF CHANGE: 20180515
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SMITH IAN F
CENTRAL INDEX KEY: 0001197032
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 18836832
MAIL ADDRESS:
STREET 1: C/O ACORDA THERAPEUTICS, INC.
STREET 2: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-05-11
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197032
SMITH IAN F
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, COO
Common Stock
2018-05-11
4
M
0
2155
91.05
A
48854
D
Common Stock
2018-05-11
4
M
0
1941
86.52
A
50795
D
Common Stock
2018-05-11
4
S
0
4096
155.00
D
46699
D
Common Stock
5306
I
401(k)
Stock Option (Right to Buy)
91.05
2018-05-11
4
M
0
2155
0.00
D
2026-02-01
Common Stock
2155
15086
D
Stock Option (Right to Buy)
86.52
2018-05-11
4
M
0
1941
0.00
D
2027-02-02
Common Stock
1941
21358
D
Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.
The option vests in 16 quarterly installments from 2/2/2016.
The option vests in 16 quarterly installments from 2/3/2017.
/s/ Omar White, Attorney-in-Fact
2018-05-15